Raymond James Financial Inc. Raises Holdings in Envista Holdings Corporation $NVST

Raymond James Financial Inc. lifted its holdings in shares of Envista Holdings Corporation (NYSE:NVST) by 10.7% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 620,295 shares of the company’s stock after buying an additional 60,030 shares during the period. Raymond James Financial Inc. owned about 0.37% of Envista worth $10,707,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of NVST. UMB Bank n.a. grew its holdings in shares of Envista by 214.4% in the 1st quarter. UMB Bank n.a. now owns 2,094 shares of the company’s stock worth $36,000 after acquiring an additional 1,428 shares during the period. Palouse Capital Management Inc. grew its holdings in shares of Envista by 14.4% in the 1st quarter. Palouse Capital Management Inc. now owns 9,444 shares of the company’s stock worth $163,000 after acquiring an additional 1,186 shares during the period. FourThought Financial Partners LLC acquired a new stake in shares of Envista in the 1st quarter worth approximately $180,000. Vestcor Inc acquired a new stake in shares of Envista in the 1st quarter worth approximately $211,000. Finally, Tower Research Capital LLC TRC grew its holdings in shares of Envista by 51.3% in the 4th quarter. Tower Research Capital LLC TRC now owns 11,057 shares of the company’s stock worth $213,000 after acquiring an additional 3,751 shares during the period.

Envista Price Performance

Shares of NYSE:NVST opened at $21.15 on Friday. The business’s fifty day moving average price is $20.29 and its two-hundred day moving average price is $18.60. The stock has a market cap of $3.51 billion, a PE ratio of 66.08, a price-to-earnings-growth ratio of 1.13 and a beta of 1.00. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.08 and a current ratio of 2.44. Envista Holdings Corporation has a one year low of $14.22 and a one year high of $23.00.

Envista (NYSE:NVST) last announced its earnings results on Thursday, July 31st. The company reported $0.26 EPS for the quarter, beating analysts’ consensus estimates of $0.24 by $0.02. Envista had a return on equity of 4.84% and a net margin of 2.11%.The firm had revenue of $682.10 million for the quarter, compared to analysts’ expectations of $638.21 million. During the same quarter in the prior year, the firm earned $0.11 EPS. Envista’s quarterly revenue was up 7.7% on a year-over-year basis. Envista has set its FY 2025 guidance at 1.050-1.15 EPS. On average, analysts forecast that Envista Holdings Corporation will post 1 EPS for the current fiscal year.

Wall Street Analyst Weigh In

NVST has been the topic of a number of research reports. Wells Fargo & Company upped their price target on Envista from $17.00 to $19.00 and gave the stock an “equal weight” rating in a report on Friday, August 1st. Baird R W upgraded Envista from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 27th. Wall Street Zen cut Envista from a “strong-buy” rating to a “buy” rating in a report on Saturday. Stifel Nicolaus increased their target price on Envista from $24.00 to $25.00 and gave the company a “buy” rating in a report on Friday, August 1st. Finally, Mizuho increased their target price on Envista from $15.00 to $18.00 and gave the company an “underperform” rating in a report on Friday, August 1st. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $20.92.

Envista Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.